Mixed Hyperlipidemia Clinical Trial
Official title:
A Multicentre, Randomized, Double-blind, Placebo-controlled, Phase III Study to Evaluate the Efficacy and Safety of SHR-1209 Combined With Lipid-lowering Agents in the Stable Treatment of Patients With Non-familial Hypercholesterolemia and Mixed Hyperlipidemia .
To evaluate the efficacy, safety, pharmacokinetics and immunogenicity of SHR-1209 subcutaneous administration in patients with non-familial hypercholesterolemia and mixed hyperlipidemia after lipid-lowering therapy
n/a
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT01012219 -
A Study to Evaluate the Effects of Laropiprant on the Antiplatelet Effects of Clopidogrel and Aspirin in Combination (MK-0524A-114)(COMPLETED)
|
Phase 1 | |
| Terminated |
NCT00134238 -
Carotid B-mode Ultrasound Study to Compare Anti-Atherosclerotic Effect of Torcetrapib/Atorvastatin to Atorvastatin.
|
Phase 3 | |
| Completed |
NCT00941603 -
Phase 2 Dose-Ranging Efficacy and Safety Trial of SCH 900271 in Participants With Primary Hypercholesterolemia or Mixed Hyperlipidemia (P05675)
|
Phase 2 | |
| Recruiting |
NCT01974297 -
Comparison of the Efficacy and Safety of AtorVastatin mOnotherapy vs. Combination Atorvastatin/Fenofibric Acid
|
N/A | |
| Completed |
NCT00345657 -
Efficacy Study of Extended-Release Niacin/Lovastatin Versus Usual Care
|
Phase 4 | |
| Completed |
NCT00289900 -
Lipid Efficacy and Safety in Participants With Mixed Hyperlipidemia (MK-0524B-024)
|
Phase 3 | |
| Completed |
NCT00269217 -
Lipid Efficacy Study (0524B-022)(COMPLETED)
|
Phase 3 | |
| Recruiting |
NCT01956201 -
Efficacy and Safety of Fenofibrate Added on to Atorvastatin Compared With Atorvastatin
|
Phase 3 | |
| Completed |
NCT02008084 -
A Pilot Study to Evaluate the Lipid Effects of TRIA-662
|
Phase 2 |